About Thesis
Thesis is a company based in New York (United States) founded in 2017 by Adam Greenfeld and Dan Freed. It operates as a Direct-to-Consumer (D2C) and Subscription Services. Thesis has raised $8.4 million across 1 funding round from investors including Unilever Ventures, REDO Ventures and ALIVE. Thesis offers products and services including Clarity, Motivation, Stress Reset, and Neuroprotection. Thesis operates in a competitive market with competitors including Panaceutics, bioniq, Wile, Gainful and Rebalance Health, among others.
- Headquarter New York, United States
- Founders Adam Greenfeld, Dan Freed
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
$1.35 M (USD)0as on Dec 31, 2022
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$8.4 M (USD)
in 1 rounds
-
Latest Funding Round
$8.4 M (USD), Series A
May 02, 2023
-
Investors
Unilever Ventures
& 3 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Thesis
Thesis offers a comprehensive portfolio of products and services, including Clarity, Motivation, Stress Reset, and Neuroprotection.
Concentration and focus are enhanced by this supplement.
Brain energy and awareness are heightened by this product.
Mental calm and resilience are supported by this formula.
Memory and brain health are supported by this supplement.
People of Thesis
Unlock access to complete
Funding Insights of Thesis
Thesis has successfully raised a total of $8.4M through 1 strategic funding round. The most recent funding activity was a Series A round of $8.4 million completed in May 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Thesis
Thesis has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Unilever Ventures, REDO Ventures and ALIVE.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Corporate-backed venture capital firm focused on consumer tech and multiple sectors
|
Locked | Locked | Locked | |
|
Investments are directed by REDO Ventures toward software technology startups.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Thesis
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Thesis
Investment portfolio details for Thesis
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Thesis
Detailed financials for Thesis
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Thesis Comparisons
Peer comparison for Thesis
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Thesis
Thesis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Panaceutics, bioniq, Wile, Gainful and Rebalance Health, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
An online platform for personalized nutrition and medication is provided.
|
|
| Locked | Locked | Locked |
AI-powered hyper-personalized supplements are delivered using user health data.
|
|
| Locked | Locked | Locked |
Personalized supplements for women's wellness are offered via quizzes.
|
|
| Locked | Locked | Locked |
Personalized protein powders and hydration products are manufactured for subscribers.
|
|
| Locked | Locked | Locked |
Nutritional supplements are provided based on questionnaires for wellness support.
|
|
| Locked | Locked | Locked |
Provider of personalised nutraceutical supplements
|
Detailed competitors of Thesis
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Thesis
Complete news archive for Thesis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Thesis
Thesis was founded in 2017 and raised its 1st funding round 6 years after it was founded.
Thesis is headquartered in New York, United States. It is registered at New York, New York, United States.
Thesis is a funded company, having raised a total of $8.4M across 1 funding round to date.
Annual revenue of Thesis is $1.35M as on Dec 31, 2022.
Thesis is engaged in creating nootropic formulas aimed at enhancing cognitive functions such as focus, memory, and stress resilience. The company operates in the health and wellness sector, offering products designed to support brain health and performance. Solutions are developed through data-driven research and iterative testing to ensure effectiveness. Various formulations target specific needs like productivity, energy, balance, and long-term neuroprotection.
Thesis offers Clarity, Motivation, Stress Reset, and Neuroprotection.
Thesis has 4 investors. Key investors include Unilever Ventures, REDO Ventures, ALIVE, and Break Trail Ventures.